Novo Nordisk B A/S

NOVO-B 
(NasdaqOMXC) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 299.90 <%= Resources.Global.txtUp %>
Updated 16:20:00
ISIN: DK0060534915
Change % 0.50% Stock price increasing
Change 1.50 Stock price increasing
Volume 3,151,618
High DKK 303.50
Low DKK 295.60
Open DKK 298.50
 
Prev close DKK 298.40
# of shares 2,112.56M
Market cap 633,558M DKK
Intraday

Market closed
Novo Nordisk B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  299.90 4.1% Stock price increasing 13.4% Stock price increasing 17.4% Stock price increasing 16.9% Stock price increasing 46.8% Stock price increasing
Key Figures (m)
Turnover
EBIT
Net Profit
Equity
Balance
2013
83,572
0
25,184
42,569
70,337
2012
78,026
28,837
21,432
40,632
65,669
2011
66,346
22,056
17,097
37,448
64,698
2010
60,776
18,302
14,403
36,965
61,402
2009
51,078
14,839
10,768
35,734
54,742
2008
45,553
12,571
9,645
32,979
50,603
2007
41,831
10,009
8,522
32,182
47,731

Company profile

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Targets for: Novo Nordisk B A/S

Fra Ritzau Finans
 
Analyst
Target
Date
Novo/Jyske: Hæver kursmål fra 315 kr. til 350 kr.
Jyske Bank
350 op
27/01/15
Novo/Barclays: Hæver kursmål til 310 kr.
Barclays
310 op
16/01/15
Novo/JPM: Løfter kursmål til 315 kr. fra 280 kr. - NY
JPMorgan
315 op
05/01/15
Novo/JPM: Løfter kursmål til 315 kr. fra 280 kr.
JPMorgan
315 op
05/01/15
Novo/Exane: Indleder dækning med
BNP Paribas
270 ingen ændring
25/11/14
Novo/SEB: Hæver kursmål til 350 kr. fra 260 kr.
SEB Enskilda
350 op
20/05/14
Novo/Jefferies: Hæver kursmål til 260 kr.
Jefferies
260 op
19/03/14
Novo/Exane: Løfter kursmål til 220 kr. fra 176 kr.
BNP Paribas
220 op
17/03/14
Novo/Barclays: Løfter kursmålet til 275
Barclays
275 op
10/03/14
Novo/S&P: Hæver kursmål til 280 kr
S&P Equity Research
280 op
07/03/14

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
29 January 2015 22:22:59
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150128.1 - EUROWEB2 - 2015-01-29 23:22:59 - 2015-01-29 22:22:59 - 1000 - Website: OKAY